CALC

CalciMedica, Inc.

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
5Trials in this database
10Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
TrialSponsorPhaseStatusPrimary completion
CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRSNCT03401190CALCPhase 2Completed2019-02-14Actual
A Study of Auxora in Patients With Severe COVID-19 PneumoniaNCT04345614CALCPhase 2Completed2021-06-28Actual
A Study of Auxora in Patients With Critical COVID-19 PneumoniaNCT04661540CALCPhase 2Terminated2021-12-21Actual
A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRSNCT04681066CALCPhase 2Completed2024-05-15Actual
A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"NCT06374797CALCPhase 2Terminated2026-04-06Actual

Latest recorded trial changes

· 5 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

150 participants (planned)

+ After

122 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

Jul 2026

+ After

6 Apr 2026

Recruitment status changed

− Before

Active not recruiting

+ After

Terminated

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: Change From Baseline in Combined CD4, CD8, and Monocyte Cell Population in BAL Fluid, as a Percent of Total WBC Population

+ After

Measure: Change From Baseline in Combined CD4, CD8, and Monocyte Cell Population in BAL Fluid, as a Percent of Total WBC Population.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: Time to Solid Food Tolerance: gMCP-Modeling Analysis for Dose-response Relationship Measure: Median Time to Solid Food Tolerance

+ After

Measure: Median Time to Solid Food Tolerance, With gMCP Modeling Analysis for Dose-response Relationship

Check registry source